Thus, it will be important to elucidate the molecular mechanisms mediated by plasma-derived EVs to determine if EVs bearing PD-L1 and/or other B7-molecules have immunosuppressive properties that may inhibit T cell activation and/or anti-tumor responses. The gene discussed is CD274; the disease is neoplasm.